Clinical Trial Update: Study to Evaluate the Safety and Effect of HIVconsv Vaccines in Combination With Histone Deacetylase Inhibitor Romidepsin on the Viral Rebound Kinetic After Treatment Interruption in Early Treated HIV-1 Infected Individuals [Phase 1]

View source ↗

Summary

A Phase 1 trial studied the safety and potential impact of combining the HIVconsv vaccine with romidepsin on viral rebound after treatment interruption in early…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HIVconsv vaccine (HIVconsv)
• Istodax (romidepsin)

Snippet

Sponsor: IrsiCaixa | Conditions: HIV | Phase 1 | Status: COMPLETED